nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0386	0.526	CbGpPWpGaD
Midodrine—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.0052	0.0709	CbGpPWpGaD
Midodrine—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00306	0.0418	CbGpPWpGaD
Midodrine—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.00292	0.00315	CcSEcCtD
Midodrine—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00291	0.00314	CcSEcCtD
Midodrine—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.0029	0.00313	CcSEcCtD
Midodrine—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.00289	0.00312	CcSEcCtD
Midodrine—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.00287	0.00309	CcSEcCtD
Midodrine—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.00284	0.00307	CcSEcCtD
Midodrine—Agitation—Cyclosporine—systemic lupus erythematosus	0.00283	0.00305	CcSEcCtD
Midodrine—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.00282	0.00304	CcSEcCtD
Midodrine—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00281	0.00303	CcSEcCtD
Midodrine—Pain—Leflunomide—systemic lupus erythematosus	0.00278	0.00301	CcSEcCtD
Midodrine—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.00276	0.00298	CcSEcCtD
Midodrine—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.00275	0.00297	CcSEcCtD
Midodrine—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.00274	0.00296	CcSEcCtD
Midodrine—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.00273	0.00295	CcSEcCtD
Midodrine—Bradycardia—Betamethasone—systemic lupus erythematosus	0.00273	0.00295	CcSEcCtD
Midodrine—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.00273	0.00294	CcSEcCtD
Midodrine—Irritability—Methotrexate—systemic lupus erythematosus	0.0027	0.00291	CcSEcCtD
Midodrine—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.00268	0.0029	CcSEcCtD
Midodrine—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.00268	0.00289	CcSEcCtD
Midodrine—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.00266	0.00287	CcSEcCtD
Midodrine—Hypertension—Cyclosporine—systemic lupus erythematosus	0.00266	0.00287	CcSEcCtD
Midodrine—Anxiety—Cyclosporine—systemic lupus erythematosus	0.00261	0.00282	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.0026	0.00281	CcSEcCtD
Midodrine—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.00259	0.0028	CcSEcCtD
Midodrine—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.00259	0.00279	CcSEcCtD
Midodrine—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.00257	0.00278	CcSEcCtD
Midodrine—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.00256	0.00277	CcSEcCtD
Midodrine—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.00255	0.00275	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.00254	0.00274	CcSEcCtD
Midodrine—Confusional state—Cyclosporine—systemic lupus erythematosus	0.00253	0.00273	CcSEcCtD
Midodrine—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.0025	0.0027	CcSEcCtD
Midodrine—Back pain—Triamcinolone—systemic lupus erythematosus	0.00249	0.00269	CcSEcCtD
Midodrine—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.00247	0.00267	CcSEcCtD
Midodrine—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.00246	0.00266	CcSEcCtD
Midodrine—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00244	0.00263	CcSEcCtD
Midodrine—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00244	0.00263	CcSEcCtD
Midodrine—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00244	0.00263	CcSEcCtD
Midodrine—Hypertension—Prednisolone—systemic lupus erythematosus	0.00242	0.00261	CcSEcCtD
Midodrine—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.0024	0.00259	CcSEcCtD
Midodrine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.00239	0.00258	CcSEcCtD
Midodrine—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00238	0.00257	CcSEcCtD
Midodrine—Bradycardia—Prednisone—systemic lupus erythematosus	0.00238	0.00257	CcSEcCtD
Midodrine—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.00236	0.00255	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.00234	0.00253	CcSEcCtD
Midodrine—Asthenia—Leflunomide—systemic lupus erythematosus	0.00234	0.00252	CcSEcCtD
Midodrine—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.00232	0.00251	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.00231	0.0025	CcSEcCtD
Midodrine—Pruritus—Leflunomide—systemic lupus erythematosus	0.0023	0.00249	CcSEcCtD
Midodrine—Dysuria—Methotrexate—systemic lupus erythematosus	0.00228	0.00246	CcSEcCtD
Midodrine—Dizziness—Azathioprine—systemic lupus erythematosus	0.00228	0.00246	CcSEcCtD
Midodrine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.00227	0.00245	CcSEcCtD
Midodrine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.00226	0.00244	CcSEcCtD
Midodrine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.00224	0.00242	CcSEcCtD
Midodrine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.00223	0.00241	CcSEcCtD
Midodrine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.00223	0.00241	CcSEcCtD
Midodrine—Hypertension—Triamcinolone—systemic lupus erythematosus	0.00223	0.0024	CcSEcCtD
Midodrine—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.00222	0.0024	CcSEcCtD
Midodrine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.00222	0.00239	CcSEcCtD
Midodrine—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.00221	0.00239	CcSEcCtD
Midodrine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.0022	0.00238	CcSEcCtD
Midodrine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.00219	0.00236	CcSEcCtD
Midodrine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00219	0.00236	CcSEcCtD
Midodrine—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.00218	0.00235	CcSEcCtD
Midodrine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.00218	0.00235	CcSEcCtD
Midodrine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.00218	0.00235	CcSEcCtD
Midodrine—Rash—Azathioprine—systemic lupus erythematosus	0.00217	0.00235	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00217	0.00235	CcSEcCtD
Midodrine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00217	0.00234	CcSEcCtD
Midodrine—Flushing—Prednisone—systemic lupus erythematosus	0.00217	0.00234	CcSEcCtD
Midodrine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00217	0.00234	CcSEcCtD
Midodrine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00217	0.00234	CcSEcCtD
Midodrine—Headache—Azathioprine—systemic lupus erythematosus	0.00216	0.00233	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	0.00216	0.00233	CcSEcCtD
Midodrine—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.00216	0.00233	CcSEcCtD
Midodrine—Dizziness—Leflunomide—systemic lupus erythematosus	0.00215	0.00232	CcSEcCtD
Midodrine—Pain—Cyclosporine—systemic lupus erythematosus	0.00215	0.00232	CcSEcCtD
Midodrine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.00215	0.00232	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—systemic lupus erythematosus	0.00212	0.00229	CcSEcCtD
Midodrine—Angiopathy—Prednisone—systemic lupus erythematosus	0.00212	0.00229	CcSEcCtD
Midodrine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00212	0.00228	CcSEcCtD
Midodrine—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.00212	0.00228	CcSEcCtD
Midodrine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.0021	0.00226	CcSEcCtD
Midodrine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.00207	0.00224	CcSEcCtD
Midodrine—Insomnia—Prednisolone—systemic lupus erythematosus	0.00207	0.00223	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.00206	0.00222	CcSEcCtD
Midodrine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00206	0.00222	CcSEcCtD
Midodrine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00206	0.00222	CcSEcCtD
Midodrine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.00205	0.00222	CcSEcCtD
Midodrine—Rash—Leflunomide—systemic lupus erythematosus	0.00205	0.00222	CcSEcCtD
Midodrine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00205	0.00222	CcSEcCtD
Midodrine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00205	0.00221	CcSEcCtD
Midodrine—Mental disorder—Prednisone—systemic lupus erythematosus	0.00205	0.00221	CcSEcCtD
Midodrine—Nausea—Azathioprine—systemic lupus erythematosus	0.00205	0.00221	CcSEcCtD
Midodrine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.00205	0.00221	CcSEcCtD
Midodrine—Headache—Leflunomide—systemic lupus erythematosus	0.00204	0.0022	CcSEcCtD
Midodrine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.00204	0.0022	CcSEcCtD
Midodrine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00202	0.00218	CcSEcCtD
Midodrine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00202	0.00218	CcSEcCtD
Midodrine—Hypertension—Betamethasone—systemic lupus erythematosus	0.00202	0.00218	CcSEcCtD
Midodrine—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00202	0.00218	CcSEcCtD
Midodrine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.00201	0.00216	CcSEcCtD
Midodrine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.002	0.00216	CcSEcCtD
Midodrine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00199	0.00214	CcSEcCtD
Midodrine—Anxiety—Betamethasone—systemic lupus erythematosus	0.00198	0.00214	CcSEcCtD
Midodrine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.00198	0.00214	CcSEcCtD
Midodrine—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00197	0.00212	CcSEcCtD
Midodrine—Pain—Prednisolone—systemic lupus erythematosus	0.00196	0.00211	CcSEcCtD
Midodrine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00194	0.00209	CcSEcCtD
Midodrine—Nausea—Leflunomide—systemic lupus erythematosus	0.00193	0.00209	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.00193	0.00208	CcSEcCtD
Midodrine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.00193	0.00208	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.00192	0.00207	CcSEcCtD
Midodrine—Pain—Hydrocortisone—systemic lupus erythematosus	0.00191	0.00206	CcSEcCtD
Midodrine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.0019	0.00205	CcSEcCtD
Midodrine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.0019	0.00205	CcSEcCtD
Midodrine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00189	0.00204	CcSEcCtD
Midodrine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00188	0.00203	CcSEcCtD
Midodrine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00188	0.00203	CcSEcCtD
Midodrine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.00188	0.00202	CcSEcCtD
Midodrine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.00187	0.00202	CcSEcCtD
Midodrine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.00187	0.00202	CcSEcCtD
Midodrine—Agitation—Prednisone—systemic lupus erythematosus	0.00187	0.00202	CcSEcCtD
Midodrine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00186	0.00201	CcSEcCtD
Midodrine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00186	0.00201	CcSEcCtD
Midodrine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.00185	0.002	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.00185	0.00199	CcSEcCtD
Midodrine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.00185	0.00199	CcSEcCtD
Midodrine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00184	0.00199	CcSEcCtD
Midodrine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00183	0.00197	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.00181	0.00196	CcSEcCtD
Midodrine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.0018	0.00195	CcSEcCtD
Midodrine—Pain—Triamcinolone—systemic lupus erythematosus	0.0018	0.00194	CcSEcCtD
Midodrine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00178	0.00192	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.00177	0.00191	CcSEcCtD
Midodrine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00177	0.00191	CcSEcCtD
Midodrine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00176	0.0019	CcSEcCtD
Midodrine—Hypertension—Prednisone—systemic lupus erythematosus	0.00176	0.0019	CcSEcCtD
Midodrine—Chills—Methotrexate—systemic lupus erythematosus	0.00175	0.00189	CcSEcCtD
Midodrine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00173	0.00187	CcSEcCtD
Midodrine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00173	0.00187	CcSEcCtD
Midodrine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00173	0.00187	CcSEcCtD
Midodrine—Anxiety—Prednisone—systemic lupus erythematosus	0.00173	0.00186	CcSEcCtD
Midodrine—Insomnia—Betamethasone—systemic lupus erythematosus	0.00173	0.00186	CcSEcCtD
Midodrine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00173	0.00186	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.00172	0.00186	CcSEcCtD
Midodrine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.00172	0.00185	CcSEcCtD
Midodrine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.00171	0.00185	CcSEcCtD
Midodrine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.00171	0.00185	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.00171	0.00185	CcSEcCtD
Midodrine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.00168	0.00181	CcSEcCtD
Midodrine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.00168	0.00181	CcSEcCtD
Midodrine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00166	0.00179	CcSEcCtD
Midodrine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00166	0.00179	CcSEcCtD
Midodrine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00165	0.00178	CcSEcCtD
Midodrine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00165	0.00178	CcSEcCtD
Midodrine—Back pain—Methotrexate—systemic lupus erythematosus	0.00165	0.00178	CcSEcCtD
Midodrine—Pain—Dexamethasone—systemic lupus erythematosus	0.00163	0.00176	CcSEcCtD
Midodrine—Pain—Betamethasone—systemic lupus erythematosus	0.00163	0.00176	CcSEcCtD
Midodrine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00163	0.00176	CcSEcCtD
Midodrine—Tachycardia—Prednisone—systemic lupus erythematosus	0.00162	0.00175	CcSEcCtD
Midodrine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00162	0.00175	CcSEcCtD
Midodrine—Skin disorder—Prednisone—systemic lupus erythematosus	0.00161	0.00174	CcSEcCtD
Midodrine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.0016	0.00173	CcSEcCtD
Midodrine—Rash—Cyclosporine—systemic lupus erythematosus	0.00158	0.00171	CcSEcCtD
Midodrine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00158	0.00171	CcSEcCtD
Midodrine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.00158	0.00171	CcSEcCtD
Midodrine—Headache—Cyclosporine—systemic lupus erythematosus	0.00157	0.0017	CcSEcCtD
Midodrine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.00157	0.0017	CcSEcCtD
Midodrine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.00157	0.0017	CcSEcCtD
Midodrine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.00156	0.00168	CcSEcCtD
Midodrine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.00156	0.00168	CcSEcCtD
Midodrine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00155	0.00167	CcSEcCtD
Midodrine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00154	0.00167	CcSEcCtD
Midodrine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00154	0.00166	CcSEcCtD
Midodrine—Dizziness—Prednisolone—systemic lupus erythematosus	0.00151	0.00163	CcSEcCtD
Midodrine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.00151	0.00163	CcSEcCtD
Midodrine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.00151	0.00163	CcSEcCtD
Midodrine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.00151	0.00163	CcSEcCtD
Midodrine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.00151	0.00162	CcSEcCtD
Midodrine—Insomnia—Prednisone—systemic lupus erythematosus	0.0015	0.00162	CcSEcCtD
Midodrine—Nausea—Cyclosporine—systemic lupus erythematosus	0.00149	0.00161	CcSEcCtD
Midodrine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.00149	0.00161	CcSEcCtD
Midodrine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00149	0.00161	CcSEcCtD
Midodrine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00148	0.0016	CcSEcCtD
Midodrine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00148	0.00159	CcSEcCtD
Midodrine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.00146	0.00158	CcSEcCtD
Midodrine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00146	0.00157	CcSEcCtD
Midodrine—Rash—Prednisolone—systemic lupus erythematosus	0.00144	0.00156	CcSEcCtD
Midodrine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00144	0.00155	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00144	0.00155	CcSEcCtD
Midodrine—Headache—Prednisolone—systemic lupus erythematosus	0.00143	0.00155	CcSEcCtD
Midodrine—Rash—Hydrocortisone—systemic lupus erythematosus	0.00141	0.00152	CcSEcCtD
Midodrine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.00141	0.00152	CcSEcCtD
Midodrine—Confusional state—Methotrexate—systemic lupus erythematosus	0.0014	0.00151	CcSEcCtD
Midodrine—Headache—Hydrocortisone—systemic lupus erythematosus	0.0014	0.00151	CcSEcCtD
Midodrine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00139	0.0015	CcSEcCtD
Midodrine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00139	0.0015	CcSEcCtD
Midodrine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.00137	0.00148	CcSEcCtD
Midodrine—SLC15A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.00137	0.0187	CbGpPWpGaD
Midodrine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.00137	0.00148	CcSEcCtD
Midodrine—Asthenia—Betamethasone—systemic lupus erythematosus	0.00137	0.00148	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.00136	0.00147	CcSEcCtD
Midodrine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.00136	0.00147	CcSEcCtD
Midodrine—Nausea—Prednisolone—systemic lupus erythematosus	0.00136	0.00147	CcSEcCtD
Midodrine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00135	0.00146	CcSEcCtD
Midodrine—Pruritus—Betamethasone—systemic lupus erythematosus	0.00135	0.00146	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.00135	0.00146	CcSEcCtD
Midodrine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00133	0.00143	CcSEcCtD
Midodrine—Rash—Triamcinolone—systemic lupus erythematosus	0.00133	0.00143	CcSEcCtD
Midodrine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.00132	0.00143	CcSEcCtD
Midodrine—Rash—Methylprednisolone—systemic lupus erythematosus	0.00132	0.00143	CcSEcCtD
Midodrine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00132	0.00143	CcSEcCtD
Midodrine—Headache—Triamcinolone—systemic lupus erythematosus	0.00132	0.00142	CcSEcCtD
Midodrine—Headache—Methylprednisolone—systemic lupus erythematosus	0.00131	0.00142	CcSEcCtD
Midodrine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.00131	0.00142	CcSEcCtD
Midodrine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00126	0.00136	CcSEcCtD
Midodrine—Dizziness—Betamethasone—systemic lupus erythematosus	0.00126	0.00136	CcSEcCtD
Midodrine—Insomnia—Methotrexate—systemic lupus erythematosus	0.00126	0.00136	CcSEcCtD
Midodrine—Nausea—Triamcinolone—systemic lupus erythematosus	0.00125	0.00135	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.00125	0.00135	CcSEcCtD
Midodrine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00125	0.00135	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.00124	0.00134	CcSEcCtD
Midodrine—Somnolence—Methotrexate—systemic lupus erythematosus	0.00123	0.00133	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.00122	0.00132	CcSEcCtD
Midodrine—Rash—Dexamethasone—systemic lupus erythematosus	0.0012	0.0013	CcSEcCtD
Midodrine—Rash—Betamethasone—systemic lupus erythematosus	0.0012	0.0013	CcSEcCtD
Midodrine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.0012	0.0013	CcSEcCtD
Midodrine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.0012	0.0013	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.0012	0.00129	CcSEcCtD
Midodrine—Headache—Dexamethasone—systemic lupus erythematosus	0.0012	0.00129	CcSEcCtD
Midodrine—Headache—Betamethasone—systemic lupus erythematosus	0.0012	0.00129	CcSEcCtD
Midodrine—Asthenia—Prednisone—systemic lupus erythematosus	0.00119	0.00129	CcSEcCtD
Midodrine—Pain—Methotrexate—systemic lupus erythematosus	0.00119	0.00128	CcSEcCtD
Midodrine—Pruritus—Prednisone—systemic lupus erythematosus	0.00118	0.00127	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.00114	0.00124	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.00114	0.00123	CcSEcCtD
Midodrine—Nausea—Betamethasone—systemic lupus erythematosus	0.00113	0.00122	CcSEcCtD
Midodrine—Nausea—Dexamethasone—systemic lupus erythematosus	0.00113	0.00122	CcSEcCtD
Midodrine—Dizziness—Prednisone—systemic lupus erythematosus	0.0011	0.00119	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.0011	0.00118	CcSEcCtD
Midodrine—Rash—Prednisone—systemic lupus erythematosus	0.00105	0.00113	CcSEcCtD
Midodrine—Dermatitis—Prednisone—systemic lupus erythematosus	0.00105	0.00113	CcSEcCtD
Midodrine—Headache—Prednisone—systemic lupus erythematosus	0.00104	0.00112	CcSEcCtD
Midodrine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000997	0.00108	CcSEcCtD
Midodrine—Nausea—Prednisone—systemic lupus erythematosus	0.000987	0.00107	CcSEcCtD
Midodrine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000983	0.00106	CcSEcCtD
Midodrine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000919	0.000991	CcSEcCtD
Midodrine—ADRA1B—LPA receptor mediated events—LYN—systemic lupus erythematosus	0.000915	0.0125	CbGpPWpGaD
Midodrine—Rash—Methotrexate—systemic lupus erythematosus	0.000876	0.000945	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000875	0.000944	CcSEcCtD
Midodrine—Headache—Methotrexate—systemic lupus erythematosus	0.00087	0.000939	CcSEcCtD
Midodrine—Nausea—Methotrexate—systemic lupus erythematosus	0.000825	0.00089	CcSEcCtD
Midodrine—ADRA1B—AMPK Signaling—ADIPOQ—systemic lupus erythematosus	0.000696	0.00949	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000696	0.00948	CbGpPWpGaD
Midodrine—ADRA1A—AMPK Signaling—ADIPOQ—systemic lupus erythematosus	0.000619	0.00843	CbGpPWpGaD
Midodrine—ADRA1A—Endothelin Pathways—NOS3—systemic lupus erythematosus	0.000519	0.00708	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—CCR5—systemic lupus erythematosus	0.000459	0.00626	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000432	0.00589	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000371	0.00505	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000359	0.00489	CbGpPWpGaD
Midodrine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000359	0.00489	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000351	0.00478	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000319	0.00434	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000314	0.00428	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000308	0.00419	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000291	0.00397	CbGpPWpGaD
Midodrine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000291	0.00396	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000282	0.00385	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—MMP9—systemic lupus erythematosus	0.000276	0.00376	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	0.000276	0.00376	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000273	0.00372	CbGpPWpGaD
Midodrine—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000272	0.00371	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000261	0.00355	CbGpPWpGaD
Midodrine—ADRA1B—AMPK Signaling—CDKN1A—systemic lupus erythematosus	0.000259	0.00353	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000259	0.00353	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000249	0.0034	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000244	0.00332	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000234	0.00319	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000231	0.00315	CbGpPWpGaD
Midodrine—ADRA1A—AMPK Signaling—CDKN1A—systemic lupus erythematosus	0.00023	0.00314	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000221	0.00302	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000208	0.00283	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000207	0.00282	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000202	0.00275	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000199	0.00272	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000198	0.0027	CbGpPWpGaD
Midodrine—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000198	0.0027	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00019	0.00259	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000184	0.0025	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000184	0.0025	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.00018	0.00245	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000177	0.00241	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000171	0.00233	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000167	0.00228	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000166	0.00226	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000164	0.00224	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000163	0.00222	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.00016	0.00218	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000159	0.00217	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000158	0.00215	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	0.000155	0.00211	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000147	0.002	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000147	0.002	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000146	0.00199	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000145	0.00197	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000142	0.00193	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00014	0.00191	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000139	0.00189	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000133	0.00181	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000132	0.0018	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000131	0.00178	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00013	0.00177	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—C3—systemic lupus erythematosus	0.000127	0.00173	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000126	0.00172	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000123	0.00168	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000122	0.00166	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00012	0.00164	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000118	0.00161	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000118	0.0016	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—F2—systemic lupus erythematosus	0.000112	0.00152	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000108	0.00148	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000108	0.00147	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000108	0.00147	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000107	0.00146	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000107	0.00145	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—C3—systemic lupus erythematosus	0.000106	0.00144	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000101	0.00137	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.0001	0.00136	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCL2—systemic lupus erythematosus	9.95e-05	0.00136	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL12—systemic lupus erythematosus	9.74e-05	0.00133	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	9.63e-05	0.00131	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCR5—systemic lupus erythematosus	9.59e-05	0.00131	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—C3—systemic lupus erythematosus	9.37e-05	0.00128	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—F2—systemic lupus erythematosus	9.27e-05	0.00126	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	9.09e-05	0.00124	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	8.9e-05	0.00121	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TLR9—systemic lupus erythematosus	8.83e-05	0.0012	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—P2RY12—systemic lupus erythematosus	8.55e-05	0.00117	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	8.3e-05	0.00113	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCL2—systemic lupus erythematosus	8.26e-05	0.00113	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—F2—systemic lupus erythematosus	8.23e-05	0.00112	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.09e-05	0.0011	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.08e-05	0.0011	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	7.91e-05	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CSK—systemic lupus erythematosus	7.87e-05	0.00107	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	7.84e-05	0.00107	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.76e-05	0.00106	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.54e-05	0.00103	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	7.38e-05	0.00101	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.35e-05	0.001	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL2—systemic lupus erythematosus	7.34e-05	0.001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TLR9—systemic lupus erythematosus	7.33e-05	0.000999	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.25e-05	0.000988	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NCF2—systemic lupus erythematosus	7.2e-05	0.000981	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—C3—systemic lupus erythematosus	7.19e-05	0.000979	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	7.18e-05	0.000979	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LYN—systemic lupus erythematosus	7.15e-05	0.000975	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.1e-05	0.000967	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—JAK1—systemic lupus erythematosus	7.05e-05	0.00096	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SH2B3—systemic lupus erythematosus	7.02e-05	0.000956	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	6.7e-05	0.000914	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	6.7e-05	0.000913	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.68e-05	0.00091	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.58e-05	0.000897	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CSK—systemic lupus erythematosus	6.53e-05	0.00089	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—C3—systemic lupus erythematosus	6.53e-05	0.000889	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TLR9—systemic lupus erythematosus	6.51e-05	0.000887	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	6.5e-05	0.000886	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.44e-05	0.000878	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—F2—systemic lupus erythematosus	6.31e-05	0.00086	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—P2RY12—systemic lupus erythematosus	6.31e-05	0.000859	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.1e-05	0.000832	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.02e-05	0.00082	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NCF2—systemic lupus erythematosus	5.98e-05	0.000814	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—C3—systemic lupus erythematosus	5.96e-05	0.000813	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.95e-05	0.000812	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LYN—systemic lupus erythematosus	5.94e-05	0.000809	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.85e-05	0.000797	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.82e-05	0.000794	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CSK—systemic lupus erythematosus	5.8e-05	0.000791	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	5.78e-05	0.000787	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.76e-05	0.000784	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—F2—systemic lupus erythematosus	5.73e-05	0.000781	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.72e-05	0.00078	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JUNB—systemic lupus erythematosus	5.65e-05	0.00077	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.54e-05	0.000755	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.46e-05	0.000744	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	5.42e-05	0.000739	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—C3—systemic lupus erythematosus	5.42e-05	0.000738	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.37e-05	0.000732	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	5.34e-05	0.000728	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NCF2—systemic lupus erythematosus	5.31e-05	0.000723	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—C3—systemic lupus erythematosus	5.3e-05	0.000722	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LYN—systemic lupus erythematosus	5.27e-05	0.000719	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—F2—systemic lupus erythematosus	5.24e-05	0.000714	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRL—systemic lupus erythematosus	5.21e-05	0.000709	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—JAK1—systemic lupus erythematosus	5.2e-05	0.000708	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SH2B3—systemic lupus erythematosus	5.17e-05	0.000705	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.11e-05	0.000696	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.92e-05	0.000671	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.85e-05	0.000661	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—C3—systemic lupus erythematosus	4.81e-05	0.000656	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.78e-05	0.000651	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—F2—systemic lupus erythematosus	4.76e-05	0.000648	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.71e-05	0.000642	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JUNB—systemic lupus erythematosus	4.69e-05	0.000639	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—F2—systemic lupus erythematosus	4.65e-05	0.000634	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.64e-05	0.000632	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.46e-05	0.000607	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRL—systemic lupus erythematosus	4.32e-05	0.000589	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.25e-05	0.000579	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.24e-05	0.000578	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.24e-05	0.000578	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—F2—systemic lupus erythematosus	4.22e-05	0.000576	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.16e-05	0.000568	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JAK1—systemic lupus erythematosus	4.16e-05	0.000567	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.96e-05	0.000539	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR5—systemic lupus erythematosus	3.94e-05	0.000538	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.89e-05	0.00053	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2—systemic lupus erythematosus	3.86e-05	0.000526	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—C3—systemic lupus erythematosus	3.85e-05	0.000525	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.85e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRL—systemic lupus erythematosus	3.84e-05	0.000523	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.76e-05	0.000513	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.53e-05	0.000481	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JAK1—systemic lupus erythematosus	3.46e-05	0.000471	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.42e-05	0.000466	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2—systemic lupus erythematosus	3.38e-05	0.000461	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—systemic lupus erythematosus	3.27e-05	0.000446	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CD80—systemic lupus erythematosus	3.24e-05	0.000442	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.23e-05	0.00044	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2—systemic lupus erythematosus	3.2e-05	0.000436	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—C3—systemic lupus erythematosus	3.2e-05	0.000436	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.13e-05	0.000427	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	3.07e-05	0.000418	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—systemic lupus erythematosus	3.02e-05	0.000411	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.91e-05	0.000396	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.87e-05	0.000391	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.84e-05	0.000388	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	2.84e-05	0.000387	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	2.81e-05	0.000383	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TYK2—systemic lupus erythematosus	2.74e-05	0.000373	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	2.69e-05	0.000367	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—systemic lupus erythematosus	2.69e-05	0.000366	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.64e-05	0.00036	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	2.5e-05	0.000341	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	2.5e-05	0.00034	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	2.39e-05	0.000326	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.33e-05	0.000317	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	2.28e-05	0.000311	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	2.27e-05	0.00031	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	2.27e-05	0.000309	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	2.23e-05	0.000304	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.22e-05	0.000303	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	2.16e-05	0.000294	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.15e-05	0.000293	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	2.05e-05	0.000279	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.02e-05	0.000275	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.98e-05	0.00027	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.94e-05	0.000264	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.93e-05	0.000263	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.89e-05	0.000258	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.88e-05	0.000257	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.79e-05	0.000244	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.78e-05	0.000243	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.78e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.72e-05	0.000234	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.7e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.68e-05	0.000229	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.67e-05	0.000228	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.67e-05	0.000227	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.61e-05	0.000219	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.59e-05	0.000217	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.58e-05	0.000216	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.51e-05	0.000205	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.5e-05	0.000204	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.48e-05	0.000201	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.44e-05	0.000196	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.43e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.34e-05	0.000183	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.31e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.31e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.11e-05	0.000152	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.09e-05	0.000149	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	9.88e-06	0.000135	CbGpPWpGaD
